Advanced Biomedical Technologies (OTCMKTS:ABMT) vs. Sintx Technologies (NASDAQ:SINT) Head-To-Head Contrast

Advanced Biomedical Technologies (OTCMKTS:ABMT) and Sintx Technologies (NASDAQ:SINT) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their dividends, profitability, valuation, institutional ownership, risk, earnings and analyst recommendations.

Insider & Institutional Ownership

18.4% of Sintx Technologies shares are held by institutional investors. 34.1% of Advanced Biomedical Technologies shares are held by company insiders. Comparatively, 4.1% of Sintx Technologies shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Profitability

This table compares Advanced Biomedical Technologies and Sintx Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Advanced Biomedical Technologies	N/A	N/A	N/A
Sintx Technologies	-1,058.60%	-366.49%	-115.04%

Risk and Volatility

Advanced Biomedical Technologies has a beta of 1.48, suggesting that its share price is 48% more volatile than the S&P 500. Comparatively, Sintx Technologies has a beta of 0.63, suggesting that its share price is 37% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Advanced Biomedical Technologies and Sintx Technologies, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Advanced Biomedical Technologies	0	0	0	0	0.00
Sintx Technologies	1	0	3	0	2.50

Sintx Technologies has a consensus target price of $9.33, suggesting a potential upside of 487.00%. Given Sintx Technologies’ stronger consensus rating and higher probable upside, analysts plainly believe Sintx Technologies is more favorable than Advanced Biomedical Technologies.

Valuation and Earnings

This table compares Advanced Biomedical Technologies and Sintx Technologies”s gross revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Advanced Biomedical Technologies	N/A	N/A	N/A	N/A	N/A
Sintx Technologies	$1.02 million	6.73	-$10.36 million	($5.07)	-0.31

Advanced Biomedical Technologies has higher earnings, but lower revenue than Sintx Technologies.

About Advanced Biomedical Technologies

Advanced Biomedical Technologies, Inc., a development stage company, designs, develops, manufactures, and markets biomaterial internal fixation devices. It offers polymer osteosynthesis devices, such as surgical screws, binding wires, rods, and related medical devices for the treatment of orthopedic trauma, sports-related medical treatment, cartilage repair, and related treatments, as well as for reconstructive dental procedures. The company was formerly known as Geostar Mineral Corporation and changed its name to Advanced Biomedical Technologies, Inc. in March 2009. Advanced Biomedical Technologies, Inc. was founded in 2002 and is based in New York, New York.

About Sintx Technologies

Sintx Technologies, Inc., an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone. The company was formerly known as Amedica Corporation. Sintx Technologies, Inc. was incorporated in 1996 and is headquartered in Salt Lake City, Utah.